| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |